Endovascular Management of Superior Mesenteric
 Artery (SMA) Aneurysm – Adequate Access is Essential
 for Success – Case Report by Tkalčić, Lovro et al.
Endovascular Management of Superior Mesenteric 
Artery (SMA) Aneurysm – Adequate Access is Essential 
for Success – Case Report
Lovro Tkalčić1ABEF, Berislav Budiselić1B, Miljenko Kovačević2AD, Siniša Knežević1D, 
Slavica Kovačić1E, Damir Miletić1E, Vjekoslav Tomulić3G, Dimitrij Kuhelj4ABCDEFG
1 Department of Radiology, Clinical Hospital Centre Rijeka, Rijeka, Croatia
2 Department of Vascular Surgery, Clinical Hospital Centre Rijeka, Rijeka, Croatia
3 Department of Cardiology, Clinical Hospital Centre Rijeka, Rijeka, Croatia
4 Clinical Radiology Institute, University Medical Centre Ljubljana, Ljubljana, Slovenia
Author’s address: Dimitrij Kuhelj, Clinical Radiology Institute, University Medical Centre Ljubljana, Zaloška 7, 
1000 Ljubljana, Slovenia, e-mail: dimitrij.kuhelj@guest.arnes.si
 Summary
 Background: An aneurysm of the superior mesenteric artery (SMA) with a diameter of 2.2 cm was found 
incidentally on an ultrasound (US) examination in a 26-year-old woman. The only known risk 
factor was an intracranial aneurysm that was found on her grandmother’s autopsy. Based on 
pregnancy planning and the current literature, endovascular management with a covered stent was 
proposed.
 Case Report: Self-expandable, covered stent (Bard, Fluency®) was implanted using a single transfemoral 
approach. A stiff guidewire and a large sheath distorted the anatomy, which resulted in an 
incomplete aneurysmal neck covering. In the absence of additional covered stents, the procedure 
was terminated. Two weeks later, computed tomographic angiography (CTA) confirmed persistent 
aneurysmal perfusion due to the incomplete neck coverage. A multidisciplinary board opted for a 
second endovascular attempt, this time with a longer covered stent via the transaxillary approach 
in order to reduce anatomical distortion. Balloon, expandable, cobalt-chrome covered stent (Jotec, 
E-ventus BX®) was implanted in the SMA, covering the aneurysmal neck and overlapping the 
previously implanted covered stent. Angiography confirmed a complete exclusion of the aneurysm.
  A control US performed three weeks later confirmed a patent covered stent and complete 
aneurysmal exclusion. There was a mild median nerve damage periprocedurally that resolved 
in three months. The most recent US control examination, performed eleven months after the 
procedure, showed an excluded aneurysm and a patent covered stent. There were no clinical signs 
of bowel ischaemia during the follow-up period.
 Conclusions: Endovascular management of SMAA proved to be safe and efficient. The “access from above” is 
probably safer and should be considered in the majority of cases with acceptable sizes of access 
vessels. Mid-term results in our patient are good and life-long follow-up is planned to prevent late 
complications.
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Background
Visceral artery aneurysms (VAA) are relatively rare, 
accounting for 5–8% of all aneurysms, and have an 
annual incidence between 0.01–0.2% [1]. Superior mesen-
teric artery aneurysms (SMAAs) are the third most com-
mon true visceral aneurysms, often affecting the proxi-
mal 5 cm of the artery [2] and accounting for 14% of all 
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C A S E  R E P O R T
VAAs [3]. Aneurysmal degeneration of the superior mesen-
teric artery occurs infrequently, but when it does, mesen-
teric ischaemia or rupture may result [4], which poses a 
potentially life-threatening condition [3]. In about 25% of 
cases, VAAs present as surgical emergencies [1], although 
the course of the disease is often asymptomatic. VAAs are 
an incidental finding in almost half of patients [5]. Around 
22% of patients with VAAs are diagnosed after rupture. 
Variable clinical manifestations pose the risk of misdiag-
nosis and unwarranted treatment with high mortality – 
8.5–25% [6,7].
The diagnosis of SMAA is sometimes based on an abdomi-
nal ultrasound examination, although a precise detection 
is often made by computed tomographic angiography (CTA) 
or magnetic resonance (MR). Calcified wall on x-rays might 
raise the suspicion of an aneurysm. Changes in the sur-
rounding organs and tissues (signs of chronic pancreatitis 
etc.) might reveal the cause of the condition. Additional 
vascular changes might be discovered, and factors influenc-
ing management should be determined by evaluating clini-
cal symptoms, laboratory findings and imaging (aneurys-
mal size, neck, access vessels etc.).
Case Report
An abdominal US examination revealed an SMAA of 
unknown aetiology in an asymptomatic 26-year-old 
woman. Initial CTA confirmed the presence of an aneu-
rysm with a diameter of 2.2 cm, originating from the proxi-
mal part of the superior mesenteric artery (SMA). Clinical 
workup included a detailed history, physical examination 
and blood analysis, including complete blood cell count, 
coagulation studies and biochemical analysis. There was 
no history of infectious or inflammatory diseases and no 
history of trauma; pancreatitis, alcohol abuse, liver disease 
and neoplasm were also excluded. The only known risk fac-
tor was a history of an intracranial aneurysm that found 
on her grandmother’s autopsy.
After a multidisciplinary consensus, taking into considera-
tion patient’s age, pregnancy planning, aneurysmal size, 
location and literature data, endovascular management 
with a covered stent was proposed. Informed consent from 
the patient was obtained before the procedure.
Due to a large size of the introducer sheath (9 Fr), required 
for the available covered stent implantation (Bard, 
Fluency®, 8×20 mm), the femoral approach was chosen. 
Digital subtraction angiography (DSA) confirmed previous 
findings (Figure 1). Selective SMA catheterisation was per-
formed with the use of a curved guiding catheter and a stiff 
guidewire (Amplatz stiff®, Cook) that was placed distally 
in a branch of the SMA. Heparin (5000 IU) was adminis-
tered into the SMA. An introducer sheath (9 Fr, 55 cm, Brite 
tip®, Cordis) was advanced into the SMA ostium and a self-
expandable covered stent was implanted. A control DSA 
showed persistent aneurysmal sack filling (Figure 2). Single 
femoral approach, a stiff guidewire and a large sheath dis-
torted the anatomy, resulting in an incomplete aneurys-
mal neck covering. Alternatively, only a rigid, stainless 
steel covered stent was available and therefore the pro-
cedure was terminated. The patient was discharged from 
the hospital on the following day without clinical signs of 
complications.
Two weeks later, CTA confirmed persistent aneurysmal 
perfusion due to incomplete neck coverage; the patient was 
still asymptomatic.
A multidisciplinary board consisting of a vascular a sur-
geon, cardiologist and interventional radiologists decided 
to opt for a second endovascular intervention. A longer 
covered stent with lower crossing profile was selected; we 
decided to preserve the stump of the SMA for a potential 
conversion to open surgery.
A left transaxillary approach was used for anatomy pres-
ervation and an 8-Fr straight guiding catheter (55 cm, 
Brite tip®, Cordis) was introduced into the SMA. Balloon, 
Figure 1.  DSA confirmed aneurysm originating from the proximal 
part of SMA.
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expandable cobalt-chromium covered stent (E-ventus 
BX®, Jotec, 8×50 mm) was placed in the SMA, covering 
the aneurysmal neck (Figure 3). A control DSA confirmed a 
complete exclusion of the aneurysm.
Complete aneurysmal exclusion and a patent covered stent 
were confirmed on control US three weeks later, and the 
patient was free of any signs of bowel ischaemia. Due to 
the transaxillary approach and 8-Fr sheath used, there was 
a mild median nerve damage periprocedurally that resolved 
in the following three months. No additional clinical signs 
of complications were noted during the follow-up period 
and an control US examination, performed 11 months later, 
showed a completely excluded aneurysm and a patent cov-
ered stent.
Discussion
We report a case of challenging endovascular treatment of 
a rare SMA aneurysm in a young patient. As seen in our 
case, SMAAs are often asymptomatic and incidental.
Complications of endovascular treatment are not uncom-
mon, since 25% of patients (9 patients) in a patient series 
[5] had persistent aneurysmal perfusion and enlargement, 
brachial artery haematoma, splenic artery dissection, liver 
abscess, infected pseudocyst or pancreatitis. Seven patients 
required one or more additional interventions. Persistent 
aneurysmal perfusion, as in our case, represented the 
most common complication of elective treatment, occur-
ring in 11% of patients in that series [5]. Thirty-three 
percent of patients (8 patients) in the surgical group had 
complications, of whom four required re-interventions. 
Complications included graft thrombosis and ileus, pseu-
doaneurysm, bile leak, intra-abdominal abscess and wound 
infections. Re-interventions were sometimes complex, 
including liver re-transplantation due to bile leak [5].
Currently, there is no clear consensus on the size of SMAAs 
that should be treated in asymptomatic patients. Surgical 
treatment of SMAA is clearly indicated in cases of rupture 
and infectious pathogenesis [8], but indications for endo-
vascular or open surgical repair of asymptomatic lesions 
remain unclear, since favourable long-term results of end-
ovascular treatment were reported in both groups [3,5,9]. 
Published series include relatively low number of patients 
and it is often difficult to extract firm data for decision-
making. The majority of publications showed similar sur-
vival and re-intervention rates in open and endovascular 
approaches, with shorter hospital stay and lower com-
plication rate for those patients treated with the latter 
Figure 2.  Control DSA showed persistent aneurysmal sack filling 
after implantation of self-expandable covered stent due to 
incomplete aneurysmal neck covering.
Figure 3.  On second attempt, balloon, expandable covered stent was 
placed in the SMA covering the aneurysmal neck – DSA 
confirmed complete exclusion of the aneurysm.
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approach [2]. There are some data showing lower inva-
siveness of endovascular management, followed by short-
er hospital stay (mean 4 vs. 17 days, p<0.01) [3], point-
ing towards endovascular management of non-ruptured 
SMAAs. A recent publication [10], including a thorough 
review of the literature, suggests an advantage of the mini-
mal invasiveness of endovascular therapy that might not be 
warranted in complicated or major aneurysms. Promising 
results with covered stents in SMA are reported also in the 
PERICLES registry, reporting results of chimney and snor-
kel stent grafts in more than 500 patients [11].
According to some authors, the aneurysmal size is impor-
tant to decide whether to treat patients, since aneurysms 
with diameters smaller than 20 mm are considered to have 
a low rupture rate [3], although one group reported aneu-
rysm size as a non-reliable predictor of VAA rupture [12]. 
Aneurysmal diameter should probably be compared to the 
size of the SMA in order to determine the ratio of arterial 
dilatation. Moreover, pregnancy planning, as in our patient, 
can be one of the reasons for the treatment – there is a 
high rupture risk during pregnancy (with high mortality 
rates) [9] and renal and splenic artery aneurysms in women 
of childbearing age should be treated in some authors’ 
opinion [3].
In our case, the decision for an endovascular treatment 
was made by a multidisciplinary team that consisted of 
vascular surgeons, cardiologists and interventional radiolo-
gists. Possible advantages and disadvantages were taken in 
consideration, including patient’s preferences.
Endovascular management offers different options, covered 
stents being only one of them. Suitable location proximally 
and a relatively accessible angle of the SMA together with 
a wide-neck aneurysm without branches were the major 
reasons for choosing a covered stent.
Coiling is also an alternative, but it would also have been 
technically challenging, although a smaller access sheath 
would have been sufficient. The aneurysm was quite large, 
requiring many coils for a complete exclusion. The neck 
was wide, so only stenting prior to coiling would have 
ensured safe coiling without distal embolization or SMA 
obstruction. Altogether, the procedure would have been 
quite complex, expensive, with long procedure time and 
considerable amount of irradiation we wanted to avoid.
Our case showed that distorted anatomy due to initial 
single femoral approach and a stiff guidewire resulted in 
inadequate positioning of the covered stent and therefore 
there was a need for re-intervention. Placing a large sheath 
into the SMA orifice, allowing for angiographic control just 
prior to deployment of the covered stent, would have prob-
ably resulted in an adequate positioning, although it might 
have increased the risk of complications (SMA dissection, 
access site haematoma etc.). An “access from above” (bra-
chial access) in patients treated for symptomatic isolated 
dissection of the SMA proved to be more successful in com-
parison to the femoral approach, and in some patients it 
was used as a rescue procedure after a failed SMA cannula-
tion [13]. Some authors conclude that selection of an arteri-
al approach should be based on the morphology of the SMA 
arch. This is initially difficult to determine due to addi-
tional distortion made by the introduction of large sheaths, 
stiff guidewires and rigid or covered stents.
Alternatively, an additional access site could be chosen, 
providing space for angiographic catheter necessary for 
angiographic control. The “access from above” was not 
selected initially due to a relatively small access vessel 
and a large sheath needed. Our case showed that “access 
from above” was more suitable and should probably be 
used in the majority of cases with acceptable sizes of access 
vessels.
Median nerve palsy in our patient was probably a compli-
cation of the transaxillary access but was mild and tempo-
rary and did not influence long-term morbidity.
The aetiology of aneurysm in our patient remained unclear. 
A large majority of all detected aneurysms (60%) are 
mycotic by aetiology [6]. Due to young age and unclear aeti-
ology of the aneurysm in our patient (except for family his-
tory), infection could be the cause. No signs of infection, as 
depicted in a publication [3], (fever, leucocytosis, pain, posi-
tive blood or tissue cultures or characteristic radiological 
findings) were detected in our patient.
The current follow-up protocol proposed for endovascular 
management of visceral aneurysms includes imaging at 
3-month intervals during the first year and annually there-
after [5]. In our case, the SMA is easily accessible by US 
that will be performed each year. CTA will be used only in 
unclear US findings and if clinical symptoms occur.
Conclusions
Endovascular management of an SMA aneurysm was safe 
and efficient in our case even after initial therapeutic fail-
ure. “Access from above” is probably safer and should be 
considered in the majority of cases with acceptable sizes of 
access vessels. Mid-term results of endovascular manage-
ment in our patient are good, although life-long follow-up 
is planned to prevent late complications.
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